Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...

Scientists say that blocking a protein called DLK could help protect against neurodegeneration of demyelinated nerve cells in ...

People with multiple sclerosis (MS) often stop taking disease-modifying ... patients tend to experience fewer relapses and less disease activity but show more evidence of neuronal degeneration.

Reference: “Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of ...

Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis, ...

New research has identified crucial links between dietary choices and the progression of multiple sclerosis (MS ... potential mechanisms by which a diet rich in palm oil may hijack neuronal health.

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Background: Multiple sclerosis is a chronic inflammatory disease ... [20] In these patients, cognitive function improved and the brain atrophy rate was significantly slowed. Here, immunomodulatory ...

New Study Finds a Promising Combined Therapy for Multiple Sclerosis Oct. 2 ... and MS that takes place in astrocytes -- important non-neuronal glial cells in the ... Pregnant Women Are Missing ...

A large, retrospective analysis of patients with amyotrophic lateral sclerosis ... muscular atrophy (PMA) indicates that a substantial proportion of PMA patients develop upper motor neuron ...